Wu Yi-Long, Tsuboi Masahiro, He Jie, John Thomas, Grohe Christian, Majem Margarita, . . . et al. (2020). Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer.
Chicago Style (17th ed.) CitationWu Yi-Long, et al. Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer. 2020.
MLA idézésWu Yi-Long, et al. Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer. 2020.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..